Circulating EVs from CAD patients via the angiotensin signaling induce higher expression of sodium-glucose cotransporter (SGLT)-2 protein promoting endothelial senescence and dysfunction as well as pro-atherothrombotic responses in coronary ECs; effects that can be targeted by SGLT-2 inhibitors [307]. This evidence concerns the gene SLC5A2 and coronary artery disorder.